Finally, the circulating granulocyte colony stimulating factor (G-CSF) was quantified to ensure that the LDN increase observed in patients with T2D was not due to infection-associated inflammation [39,40,41]. The gene discussed is CSF3; the disease is type 2 diabetes mellitus.